Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Mar-24 4:30 PM View:  | Nkarta, Inc. (NKTX) | 27-Mar-24 | Private Purchase | 2,000,000 | $10.00 | $20,000,000.00 | 150% 1.33M to 3.33M | |
| 27-Feb-24 6:39 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Feb-24 | Grant | 1,048,950 | $71.50 | $75,000,000.00 | 100% 0 to 1.05M | (3%) |
| 20-Dec-22 6:45 PM View: | Design Therapeutics, Inc. (DSGN) | 20-Dec-22 | Purchase Duplicate | 40,000 | $8.14 | $325,432.00 | < 1% 6.49M to 6.53M | |
| 20-Dec-22 6:45 PM View: | Design Therapeutics, Inc. (DSGN) | 19-Dec-22 | Purchase Duplicate | 360,000 | $8.63 | $3,108,100.00 | 6% 6.13M to 6.49M | |
| 20-Dec-22 6:45 PM View: | Design Therapeutics, Inc. (DSGN) | 16-Dec-22 | Private Purchase Duplicate | 500,000 | $8.28 | $4,140,550.00 | 9% 5.63M to 6.13M | |
| 17-Aug-22 4:40 PM View: | Turning Point Therapeutics,... (TPTX) | 17-Aug-22 | Disposition | 2,253,660 | $76.00 | $171,278,000.00 | (100%) 2.25M to 0 | |
| 29-Apr-22 4:27 PM View: | Nkarta, Inc. (NKTX) | 28-Apr-22 | Private Purchase | 1,333,330 | $15.00 | $20,000,000.00 | 100% 0 to 1.33M | |
| 01-Apr-21 6:18 PM View: | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion Duplicate | 5,376,480 | -- | -- | 100% 0 to 5.38M | |
| 01-Apr-21 6:18 PM View: | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase Duplicate | 250,000 | $20.00 | $5,000,000.00 | 5% 5.38M to 5.63M | |
| 28-Sep-20 5:27 PM View: | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 2,982,860 | $100.00 | $298,286,016.00 | (100%) 2.98M to 0 | |
| 26-May-20 5:57 PM View: | Turning Point Therapeutics,... (TPTX) | 21-May-20 | Market Purchase Duplicate | 83,333 | $60.00 | $4,999,980.00 | 4% 2.17M to 2.25M | 124% |
| 22-Oct-19 4:11 PM View: | Principia Biopharma Inc. (PRNB) | 18-Oct-19 | Private Purchase | 357,142 | $28.00 | $9,999,980.00 | 14% 2.63M to 2.98M | |
| 11-Sep-19 6:42 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Sep-19 | Market Purchase | 177,777 | $45.00 | $7,999,960.00 | 9% 1.99M to 2.17M | 199% |
| 24-Apr-19 6:04 PM View: | Turning Point Therapeutics,... (TPTX) | 22-Apr-19 | Conversion | 1,667,550 | -- | -- | 100% 0 to 1.67M | |
| 24-Apr-19 6:04 PM View: | Turning Point Therapeutics,... (TPTX) | 22-Apr-19 | Purchase | 325,000 | $18.00 | $5,850,000.00 | 19% 1.67M to 1.99M | |
| 20-Sep-18 6:50 PM View: | Principia Biopharma Inc. (PRNB) | 18-Sep-18 | Conversion Duplicate | 2,355,710 | -- | -- | 100% 0 to 2.36M | |
| 20-Sep-18 6:50 PM View: | Principia Biopharma Inc. (PRNB) | 18-Sep-18 | Purchase Duplicate | 270,000 | $17.00 | $4,590,000.00 | 11% 2.36M to 2.63M | |
| 26-Oct-16 5:51 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Conversion Duplicate | 3,154,130 | -- | -- | 100% 0 to 3.15M | |
| 26-Oct-16 5:51 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Purchase Duplicate | 66,500 | $14.00 | $931,000.00 | 2% 3.15M to 3.22M | |
| 11-Feb-14 9:49 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Conversion | 1,527,890 | -- | -- | 100% 0 to 1.53M | |
| 11-Feb-14 9:49 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Purchase | 143,773 | $12.00 | $1,725,280.00 | 9% 1.53M to 1.67M |